The multicenter, randomized REACH2 trial demonstrated that ruxolitinib is efficacious and safe for patients with aGVHD after allogeneic stem cell transplantation.
The National Comprehensive Cancer Network offers guidelines designed to protect patients and nurses while continuing needed cancer care during the COVID-19 pandemic.
In a web-based survey, oncology nurses self-report on their ability to assess the nutritional status of pediatric patients and their confidence in their assessments.
Researchers found that nutrition status and activity levels have a more significant influence on outcomes for participants in phase 1 and 2 clinical trials of cancer drugs than previously believed.
A long-term study sought to delineate risk factors for male breast cancer and to identify the potential benefits of screening mammography for men at high risk of breast cancer.
A literature review identified CIPN as a potential contributor to falls and injuries in patients with cancer; however, evidence-based methods for preventing falls in these patients are scarce.
A team of researchers sought to determine if BWH Tumor Classification System classified tumors more accurately than AJCC 8, and their sensitivity and specificity for predicting poor outcomes.
Oncology nurses discuss the importance of ongoing education on the treatments, symptoms, and available information on MPNs for patients, and oncology nurses.
A pilot study revealed the effectiveness of the DLQI in assessing quality of life measures in women with breast cancer treatment-related radiodermatitis.
These study results illustrate a need to educate survivors of childhood cancers on an ongoing potential risk for venous thromboembolism (VTE) beyond 5 years postdiagnosis.